Yeast-based assays for detection and characterization of mutations in BRCA1

Breast Disease

Volumn 10, Issue 1-2, 1998, Pages 61-70

  Monteiro, Alvaro N A ^a   Humphrey, Jeffrey S ^b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

BRCA1; Breast cancer; Diagnostics; Functional assay; Mutation; Tumor suppressor gene

Indexed keywords

BRCA1 PROTEIN;

BREAST CANCER; CANCER SUSCEPTIBILITY; DIAGNOSTIC TEST; GENE MUTATION; GENETIC SUSCEPTIBILITY; GERM LINE; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE; YEAST;

EID: 0031946411     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/BD-1998-101-208     Document Type: Review

References (54)

1. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991; 48:232-242.
2. Newman B, Austin MA, Lee M, King M-C. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 1988; 85:3044-3048.
3. Easton DF, Bishop DT, Ford D, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Breast Cancer Linkage Consortium. Am J Hum Genet 1993; 52:678-701.
4. Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 1995; 56:265-271.
5. Szabo CI, King MC. Inherited breast cancer. Hum Mol Genet 1995; 4:1811-1817.
6. Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336:401-1408.
7. Breast Cancer Information Core, 1997; http://www.nhgri.nih.gov/Intramural_research/ Lab_transfer/Bic/.
8. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266:66-71.
9. Friedman LS, Ostermeyer EA, Szabo CI, et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 1994; 8:399-404.
10. Castilla LH, Couch FJ, Erdos MR, et al. Mutations in the BRCA1 gene in families with early onset breast and ovarian cancer. Nat Genet 1994; 8:387-391.
11. Futreal PA, Liu Q, Shattuck-Eidens D, et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994; 266:120-122.
12. Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250:1684-1689.
13. Chen Y, Chen C-F, Riley DJ, et al. Aberrant subcellular localization of BRCA1 in breast cancer. Science 1995; 270:789-791.
14. Scully R, Ganesan S, Brown M, et al. Location of BRCA1 in human breast and ovarian cancer cells. Science 1996; 272:123-125.
15. Thomas JE, Smith M, Rubinfeld B, et al. Subcellular localization and analysis of apparent 180-kDa and 220-kDa proteins of the breast cancer susceptibility gene, BRCA1. J Biol Chem 1996; 271(45):28630-28635.
16. Ruffner H, Verma IM. BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc Natl Acad Sci USA 1997; 94:7138-7143.
17. Chen CF, Li S, Chen Y, Chen P-L, Sharp ZD, Lee W-H. The nuclear localization sequences of the BRCA1 protein interact with the importin-α subunit of the nuclear transport signal receptor. J Biol Chem 1996; 271:32863-32868.
18. Thakur S, Zhang HB, Peng Y, et al. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol Cell Biol 1997; 17:444-452.
19. Koonin EV, Altschul SF, Bork P. Functional Motifs. Nat Genet 1996; 13:266-267.
20. Scully R, Chen J, Plug A, et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 1997; 88:265-275.
21. Scully R, Chen J, Ochs RL, et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 1997; 90:1-20.
22. Glebov OK, McKenzie KE, White CA, Sukumar S. Frequent p53 gene mutations and novel alleles in familial breast cancer. Cancer Res 1994; 54:3703-3709.
23. Couch FJ, Weber BL. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. The Breast Cancer Information Core. Hum Mutat 1996; 8:8-18.
24. Langston AA, Malone KE, Thompson JD, Daling JR, Ostrander EA. BRCA1 mutations in a population-based sample of young women with-breast cancer. N Engl J Med 1996; 334:137-142.
25. Dunning AM, Chiano M, Smith NR, et al. Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. Hum Mol Genet 1997; 6:285-289.
26. Ishioka C, Frebourg T, Yan YX, et al. Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat Genet 1993; 5:124-129.
27. Flaman JM, Frebourg T, Moreau V, et al. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 1995; 92:3963-3967.
28. Inga A, Iannone R, Monti P, et al. Determining mutational fingerprints at the human p53 locus with a yeast functional assay: a new tool for molecular epidemiology. Oncogene 1997; 14:1307-1313.
29. Freedman DA, Epstein CB, Roth JC, Levine AJ. A genetic approach to mapping the p53 binding site in the MDM2 protein. Mol Med 1997; 3:248-259.
30. Ishioka C, Suzuki T, FitzGerald M, et al. Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast. Proc Natl Acad Sci USA 1997; 94:2449-2453.
31. Van Dijk MAJ, Floore AN, Kloppenborg KIM, van Veer LJ. A functional assay in yeast for the human estrogen receptor displays wild-type and variant estrogen receptor messenger RNAs present in breast carcinoma. Cancer Res 1997; 57:3478-3485.
32. Friend S. p53: a glimpse at the puppet behind the shadow play. Science 1994; 265:334-335.
33. Szabo CI, Wagner LA, Francisco LV, et al. Human, canine and murine BRCA1 genes: sequence comparison among species. Hum Mol Genet 1996; 5:1289-1298.
34. Bork P, Hofmann K, Bucher P, et al. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J 1997; 11:68-76.
35. Callebaut I, Mornon JP. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett 1997; 400:25-30.
36. Monteiro ANA, August A, Hanafusa H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci USA 1996; 93:13595-13599.
37. Humphrey JS, Salim A, Erdos MR, Collins FS, Brody LC, Klausner RD. Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing. Proc Natl Acad Sci USA 1997; 94:5820-5825.
38. Chapman MS, Verma IM. Transcription activation by BRCA1. Nature 1996; 382:678-679.
39. Scully R, Anderson SF, Chao DM, et al. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc Natl Acad Sci USA 1997; 94:5605-5610.
40. Monteiro ANA, August A, and Hanafusa H. Common BRCA1 variants and transcription activation. Am J Hum Genet 1997; 61:761-762.
41. Milner J, Ponder B, Hughes-Davies L, Seltmann M, Kouzarides T. Transcriptional activation functions in BRCA2. Nat Genet 1997; 386:772-773.
42. Gill G, Ptashne M. Negative effect of the transcriptional activator GAL4. Nature 1988; 334:721-724.
43. Struewing JP, Abeliovich D, Peretz T, et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 1995; 11:198-200.
44. Lancaster JM, Cochran CJ, Brownlee HA, et al. Detection of BRCA1 mutations in women with early-onset ovarian cancer by use of the protein truncation test. J Natl Can Inst 1996; 88:552-554.
45. Wu LC, Wang ZW, Tsan JT, et al. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet 1996; 14:430-440.
46. Merajver SD, Pham TM, Caduff RF, et al. Somatic mutations in the BRCA1 gene in sporadic ovarian tumors. Nat Genet 1995; 9:439-443.
47. Roest PAM, Roberts RG, Sugino S, van Ommen GJ, den Dunnen JT. Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum Mol Genet 1993; 2:1719-1721.
48. Hogervorst FBL, Cornelis RS, Bout M, et al. Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet 1995; 10:208-212.
49. Grompe M. The rapid detection of unknown mutations in nucleic acids. Nat Genet 1993; 5:111-115.
50. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand comformation polymorphism. Proc Natl Acad Sci 1989; 86:2766-2770.
51. Sheffield VC, Beck JS, Kwitek AE, Sandstrom DW, Stone EM. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitution. Genomics 1993; 16:325-332.
52. Fischer SG, Lerman LS. DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory. Proc Natl Acad Sci USA 1983; 80:1579-1583.
53. Stoppa-Lyonet D, Laurent-Puig P, Essioux L, et al. BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Am J Hum Genet 1997; 60:1021-1030.
54. Hamelin R, Jego N, Laurent-Puig P, Vidaud M, Thomas G. Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors. Oncogene 1993; 8:2213-2220.